SCHEMBL1443640

SCHEMBL1443640

CCC(CC)(C(=O)O)C(=O)ONC(C)=O

nearest known ligand 0.36

Predicted protein targets (top 8)

geneUniProtsupporting neighboursconfidence
PKM P14618 2/20 0.32
KDM4E B2RXH2 1/20 0.32
THRB P10828 2/20 0.31
MEN1 O00255 1/20 0.31
ALDH1A1 P00352 1/20 0.31
CYP1A2 P05177 1/20 0.31
KMT2A Q03164 1/20 0.31
HTT P42858 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL9437629 0.90 PKM (0.34) PKMKDM4ETHRBMEN1KMT2A
SCHEMBL11034068 0.81 KDM4E (0.30) PKMKDM4E
SCHEMBL28125150 0.81 KDM4E (0.30) PKMKDM4E
SCHEMBL16989821 0.79 PTPN1 (0.30)
SCHEMBL221073 0.78 PTPN1 (0.40) THRBMEN1ALDH1A1CYP1A2KMT2A
SCHEMBL876236 0.78 MEN1 (0.32) MEN1CYP1A2KMT2A
SCHEMBL14861290 0.78 CTSK (0.38) MEN1CYP1A2KMT2AHTT
SCHEMBL19821900 0.75 PKM (0.33) PKMKDM4ETHRBHTT
SCHEMBL8580311 0.74 PKM (0.32) PKM
SCHEMBL6130103 0.74 MEN1 (0.34) THRBMEN1ALDH1A1CYP1A2KMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 91 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-119455852-A Reaction kettle for preparing acetamido diethyl malonate by reaction 湖北江田精密化学股份有限公司 2025-02-18 CN claimed
CN-119698408-A Process for preparing substituted benzamides 安道麦马克西姆有限公司 2025-03-25 CN disclosed
CN-119455852-A Reaction kettle for preparing acetamido diethyl malonate by reaction 湖北江田精密化学股份有限公司 2025-02-18 CN disclosed
CN-118086431-B Method for introducing alpha-hydroxy acids into proteins 修实生物医药(如东)有限公司 2025-01-03 CN disclosed
CN-117623973-A Resolution method of N-acetyl-4-trifluoromethyl phenylalanine and application thereof 瑞博(杭州)医药科技有限公司 2024-03-01 CN disclosed
CN-116854609-A Preparation method of diethyl acetamino malonate 湖北江田精密化学股份有限公司 2023-10-10 CN disclosed
CN-116854609-A Preparation method of diethyl acetamino malonate 湖北江田精密化学股份有限公司 2023-10-10 CN disclosed
CN-219291429-U Reaction kettle for preparing diethyl acetamino malonate through reaction 湖北江田精密化学股份有限公司 2023-07-04 CN disclosed
US-20220153684-A1 PROCESS FOR PREPARATION OF FINGOLIMOD HYDROCHLORIDE SHIVALIK RASAYAN LIMITED (IN) 2022-05-19 US disclosed
US-10842893-B2 Multifunctional chelators, complexes, and compositions thereof, and methods of using same ILLINOIS INSTITUTE OF TECHNOLOGY (US) 2020-11-24 US disclosed
US-5340802-A Central nervous system disorders ABBOTT LABORATORIES (US) 1994-08-23 US disclosed
US-5332746-A 8,9-annelated-β-carbolines and 8,9-annelated 3,4-dihydro-β-carbolines DUPHAR INTERNATIONAL RESEARCH B.V. (NL) 1994-07-26 US disclosed
US-5238923-A Treating hypertension, hyperaldosteronism, congestive heart failure WARNER-LAMBERT COMPANY (US) 1993-08-24 US disclosed
US-5216161-A PROCESS FOR PREPARING 2,5-DIAMINO-4,6-DICHLOROPYRIMIDINE BEECHAM GROUP P.L.C. (GB) 1993-06-01 US disclosed
EP-0405506-A1 Tetrapeptide type-B CCK receptor ligands ABBOTT LABORATORIES (US) 1991-01-02 EP disclosed
EP-0399556-A1 Amino-substituted heterocycles as renin inhibitors WARNER-LAMBERT COMPANY (US) 1990-11-28 EP disclosed
EP-0347980-A1 8,9-Annelated beta-carbolines and 8,9-anelated-3,4-dihydro-beta-carbolines DUPHAR INTERNATIONAL RESEARCH B.V (NL) 1989-12-27 EP disclosed
US-4483853-A ANTICONVULSANTS COLLINS JAMES F 1984-11-20 US disclosed
US-4477391-A Amino acid isomers, their production and their medicinal use COLLINS JAMES F (GB) 1984-10-16 US disclosed
US-4170654-A Antihypertensive compositions containing N-heterocyclicalanines and α- MERCK & CO., INC. (US) 1979-10-09 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20220153684-A1 PROCESS FOR PREPARATION OF FINGOLIMOD HYDROCHLORIDE S1PR2, S1PR4, S1PR5 PKM 365/4885KDM4E 92/4885THRB 2451/4885
US-10842893-B2 Multifunctional chelators, complexes, and compositions thereof, and methods of using same FECH, SLC40A1, TFRC PKM 1362/4885KDM4E 3507/4885THRB 4115/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.